«

Dr. Michael Mithoefer

ADVISOR

Dr-Mithoefer

Michael Mithoefer, M.D., began collaborating with MAPS in 2000 on the first U.S. Phase 2 clinical trial of MDMA-assisted  psychotherapy.

He has since conducted two of the six MAPS-sponsored Phase 2 clinical trials testing MDMA-Assisted Psychotherapy for PTSD, as well a study providing MDMA-assisted  sessions for therapists who have completed the MAPS-sponsored  MDMA Therapy Training Program, and a pilot study treating couples  with MDMA-Assisted Psychotherapy combined with Cognitive-Behavioural Conjoint Therapy.

He is now Senior Medical Director for  Medical Affairs, Training and Supervision at MAPS Public Benefit Corporation (MAPS PBC). He is a Grof-certified Holotropic Breathwork Facilitator, is trained in EMDR and Internal Family Systems Therapy, and has nearly 30 years of experience treating trauma patients.

Sign Up for Newsletter

Awakn_logo_corp

MAIN OFFICE
Awakn Life Sciences Corp
301-217 Queen St. W
Toronto, Ontario M5V 0R2
Canada

© 2023 Awakn Life Sciences Corp      |      Privacy Policy      |      Disclaimer

// ABOUT US SUB NAV // THERAPEUTIC FOCUS SUB NAV // R&D SUB NAV
Back to top Arrow